Sigma Healthcare withdrew from the Boots sale process, ending its pursuit of the British pharmacy chain in a deal valued up to $10 billion. The Australian company said the acquisition would not meet its strategic and capital investment objectives. Sigma shares rose as much as 8% on the news.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Meta reverses $2 billion AI acquisition amid China pressure